| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $16.9M | -1.5% | +18.2% |
| SG&A Expense | $5.0M | -3.6% | -6.7% |
| Operating Income | -$21.9M | +2.0% | -11.5% |
| Pre-tax Income | -$19.0M | -0.1% | -7.4% |
| Income Tax | $0 | -100.0% | — |
| Net Income | -$19.0M | +4.7% | -7.4% |
| EPS (Basic) | -$1.02 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $268.4M | -6.6% | +68.7% |
| Current Assets | $273.2M | -6.1% | +68.0% |
| Total Assets | $277.0M | -6.2% | +64.2% |
| Current Liabilities | $9.4M | -17.5% | -45.9% |
| Total Liabilities | $9.5M | -18.0% | -48.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.6M | — | — |
| Capital Expenditures | $208K | — | — |
| Investing Cash Flow | -$138K | — | — |
| Financing Cash Flow | $173.5M | — | — |
| Free Cash Flow | -$45.8M | — | — |
| +15.0% |
| EPS (Diluted) | -$1.02 | +4.7% | +15.0% |
| $267.5M |
| -5.7% |
| +77.9% |